Seqirus, GlaxoSmithKline to Produce Flu Vaccine Vials for US Military, Civilian Agencies
Seqirus and GlaxoSmithKline have each won a contract worth $18.1 million and $17.1 million, respectively, from the Defense Logistics Agency to manufacture multi-dose influenza vaccine vials. The pharmaceutical companies will produce the vials for the U.S. Army, Navy, Air Force, Marine Corps and federal civilian agencies under their one-year contracts, the Defense Department said Wednesday. […] More